Abstract
Background
Evaluation of activities of daily living (ADL) and functional exercise capacity in patients with multiple sclerosis (pwMS) is crucial in demonstrating the effectiveness of interventions.
Aims
To investigate the reliability and validity of the Glittre ADL Test in pwMS.
Methods
Twenty-five pwMS and 26 healthy adults were included in this methodological study. The Glittre ADL Test was applied. Six-Minute Walk Test (6MWT) and Nottingham Extended Activities of Daily Living Index (NEADL) were applied for concurrent validity. Expanded Disability Status Scale (EDSS), Fatigue Severity Scale (FSS), Mini Balance Evaluation Systems Test (Mini BESTest), Multiple Sclerosis Quality of Life Scale-54 (MSQoL-54), and Five Times Sit-to-Stand Test (5 STST) were applied for construct validity. The Glittre ADL Test was repeated after 3–6 days for test–retest reliability.
Results
The test–retest reliability of the Glittre ADL Test was excellent (ICC = 0.941). There was strong correlation of the Glittre ADL Test with 6MWT (rho = − 0.710, p < 0.001), NEADL (rho = − 0.841, p < 0.001), EDSS, (rho = 0.836, p = < 0.001), Mini BESTest (rho = 0.792, p < 0.001), and 5 STST scores (rho = 0.720, p < 0.001). There was a moderate correlation between the Glittre ADL Test and the physical health sub-item score of the MSQoL-54 (rho = − 0.591, p = 0.002). No correlation was found between the Glittre ADL Test and FSS (rho = 0.348, p = 0.096). There was a difference in the Glittre ADL Test results between the pwMS and the healthy adults (p = 0.001).
Conclusions
The Glittre ADL Test has excellent reliability and strong construct and criterion validity for assessing functional exercise capacity and ADL in fully ambulatory pwMS.
Trial registration
TRN: NCT04182269
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Multiple sclerosis (MS) is a chronic inflammatory disease characterized by demyelination and axonal loss in the central nervous system (CNS) [1]. Spasticity, fatigue, loss of muscle strength, tremor, balance problems, exercise intolerance, and cognitive abnormalities are some of the clinical symptoms of MS [2]. Patients’ daily living activities are negatively impacted by symptoms, resulting in a decrease in their quality of life [3]. Furthermore, a decrease in MS patients’ functional exercise capacity as a result of a reduction in physical activity levels is another factor that contributes to limitations in daily living activities [4,5,6].
To evaluate functional exercise capacity, a variety of assessment methods are used [7]. Maximal cardiopulmonary exercise tests (CPET) are considered the gold standard among these tests [8]. Furthermore, submaximal exercise tests are used to assess functional exercise capacity. As most activities of daily living (ADL) are performed at a submaximal level, submaximal tests can better determine individuals’ functional levels in these activities [9]. The 6-Minute Walk Test (6MWT) is the submaximal exercise test used most commonly in patients with multiple sclerosis (pwMS). However, it only evaluates lower extremity functions. In addition to lower extremity dysfunctions, upper extremity dysfunction is also quite common in pwMS. This situation further increases the limitation in daily living activities and causes a decrease in the quality of life of the patients [10]. Therefore, there is a need for a test that considers the upper extremity.
The Glittre ADL Test was developed to measure functional exercise capacity in chronic obstructive pulmonary disease (COPD) patients by selecting tasks that are similar to the ADL that patients have the most difficulty with in their daily lives [11, 12]. Moreover, it has been established that the Glittre ADL Test is valid and reliable across a wide range of systemic and neurological illnesses [13,14,15,16,17,18,19,20].
The purpose of the present study was to investigate the test–retest reliability, criterion, and construct validity of the Glittre ADL Test in assessing functional exercise capacity and ADL in pwMS.
Methods
Participants
This study was conducted at Hacettepe University, Faculty of Physical Therapy. Twenty-five pwMS and age-/sex-matched 26 healthy volunteers were included present study. All participants signed the written informed consent form before the study. The study was carried out in accordance with the Declaration of Helsinki’s Ethical Rules, and the local ethics committee granted approval (GO 18/856–24). The eligibility criteria were as follows: (1) being between the ages of 18 and 65, (2) having relapsing–remitting multiple sclerosis (RRMS) type MS, (3) having a maximum score of 4 from the Expanded Disability Status Scale (EDSS), (4) not changing medication in the last 6 months, (5) not having an attack in the last 3 months, (6) getting more than 24 points from the Standardized Mini Mental Status Test. The exclusion criteria were as follows: (1) using a walking aid or orthosis, (2) having a neurological disease other than MS, (3) having orthopedic or rheumatologic problems that will affect function, (4) having a peripheral vestibular problem, (5) having a cardiovascular or pulmonary disease. The inclusion criterion for healthy participants was the absence of any known disease and the agreement to participate in the study voluntarily.
Outcome measurements
To avoid fatigue, the participants’ evaluations were conducted on two different days at similar intensities. With the supervision of a physical therapist, the participants completed performance-based and self-report evaluations. The evaluations included the Glittre ADL Test [11], 6MWT [9], Nottingham Extended Activity of Daily Living Index (NEADL) [21], Fatigue Severity Scale (FSS) [22], Mini Balance Evaluation Systems Test (Mini BESTest) [23, 24], Multiple Sclerosis Quality of Life Scale-54 (MSQoL-54) [25], and Five Times Sit-to-Stand Test (5 STST) [26]. Furthermore, the Glittre ADL Test was administered twice on the same day with a half-hour interval to determine whether there was a learning effect. The results of the second Glittre ADL Test from these two assessments were used in the analysis of validity and reliability, as well as in the analysis of construct validity. For reliability analysis, the Glittre ADL Test was repeated 3–6 days later.
Glittre activities of daily living test
The Glittre ADL Test was used to evaluate functional exercise capacity. This test, as described by Skumlien et al. [11], consists of the following tasks: walking over a flat surface, stair ascending and descending, transferring objects from one shelf to another (as well as placing them on the floor and back on the shelves), and rising from and sitting in a chair. The female participants carried a 2.5-kg backpack, whereas the male participants carried a 5.0-kg backpack. The participants’ dyspnea, heart rate, blood pressure, and oxygen saturation were measured before the test, and as soon as the test was over the time taken to complete it was recorded [11]. The reference equation developed by Reis et al. [27] was used to calculate the normal values of the Glittre ADL Test in healthy individuals.
Six-minute walk test (6MWT)
The 6MWT was used as a criterion measure to assess functional exercise capacity. Following resting measures, the 6MWT was performed according to the standards of the American Thoracic Society [9]. Blood pressure, heart rate, oxygen saturation, dyspnea, and perception of fatigue were all measured before and after the test, and the total distance walked was recorded. The reference equation developed by Gibbons et al. [28] was used to calculate the expected 6MWT distance.
Nottingham extended activity of daily living index (NEADL)
The NEADL was used as a criterion measure to assess activities of daily living. The scale consists of 22 questions. The participants answered questions by choosing from the following options: “on your own” (3 points), “on your own with difficulty” (2 points), “with help” (1 point), and “not at all” (0 points). The highest score is 66. Low points indicate an increased limitation in ADL [21, 29].
Fatigue severity scale (FSS)
The FSS consists of 9 items and each item is scored between 1 and 7 (1 indicates “strongly disagree,” 7 indicates “strongly agree”). The FSS score was calculated by adding all points from items and averaging. A high score indicates increased severity of fatigue [22, 30].
Mini balance evaluation systems test (Mini BESTest)
The Mini BESTest consists of 4 subscales, namely preparatory movement, reactive postural control, sensory orientation, and dynamic walking, and a total of 14 items. Each tested condition is given 1 to 3 points (0, severe; 1, moderate; and 2, normal) according to the patients’ performance in the tested situation. The highest score that can be obtained from the test is 28. A decrease in the score obtained from the test indicates a worsening in physical condition [23].
Multiple sclerosis quality of life scale-54 (MSQoL-54)
This scale consists of 14 subscales and 54 items. Subscales that give information about the physical and mental states are grouped and two separate point totals are obtained as physical and mental health composite scores. While 100 points represent the best condition, 0 points represent the worst [25]. Only the physical health sub-item score of the MSQoL-54 scale was used in the analyses since functional exercise capacity assessment is our primary measurement.
Five times sit-to-stand test (5 STST)
This test is used to evaluate the lower extremity’s general muscle strength. It was carried out using the protocol specified by Moller et al. [26]. The participants, who were sitting on a chair without arm support with their arms crossed on their chest, were asked to stand up and sit down 5 times and to do the test as fast as they could. A manually controlled electronic stopwatch was used to record the time it took to complete the test.
Statistical analysis
Statistical analysis of the data was performed with SPSS (IBM SPSS Statistics 23). Normality tests were performed. As descriptive statistics, mean and standard deviation were given if the numerical variables met the normal distribution conditions, while median and minimum–maximum values were given if they did not, and frequency and percentage values were given for the qualitative variables. For the statistical analysis of the data obtained from the study, the level of significance was set at 0.05.
Test–retest reliability: test–retest reliability was evaluated with the intraclass correlation coefficient (ICC).
Criterion validity
-
1
Concurrent validity: the relationship between the time to complete the Glittre ADL Test and the total distance covered in the 6MWT and NEADL was determined by Spearman’s correlation analysis.
-
2
Predictive validity: the performance of the Glittre ADL Test in differentiating different subgroups of MS [(mild: EDSS ≤ 2) and (moderate: EDSS 2.5–4)] was examined. For this purpose, receiver operating characteristic (ROC) analysis was performed. The area under the ROC curve was calculated [(area under the curve (AUC)]. An AUC of 0.50 indicated non-sensitivity, while an AUC of 1.00 indicated perfect sensitivity and specificity [31].
Construct validity
construct validity was investigated with hypothesis tests. The relationships between the time to complete the Glittre ADL Test and the EDSS, FSS, Mini BESTest, physical health sub-item of the MSQoL-54, and 5 STST assessment scores were analyzed by Spearman’s correlation analysis. The classification described by Dancey and Reidy was used to interpret the strength of the correlations (0.1–0.3 = weak correlation, 0.4–0.6 = moderate correlation, ≥ 0.7 = strong correlation) [32].
Known group validity
the difference between the completion times of the Glittre ADL Test of the patient and healthy control groups was compared using the Mann–Whitney U Test.
Results
The study was completed with 51 participants, 25 pwMS with a maximum EDSS score of 4 (MS group), and 26 healthy individuals (HC group). There was no difference in baseline characteristics between the groups (p > 0.05) (Table 1). It was determined that the study was completed with 97% power according to the post hoc power analysis.
Learning effect
When the first and second Glittre ADL Test results obtained on the same day were compared, it was found that the second test (2.96 ± 0.72) took less time to perform than the first (3.28 ± 0.82) (p < 0.001). This result showed that a learning effect occurred with the second application of the Glittre ADL Test. The results of the second test were used in all statistics.
Test–retest reliability
Reliability was excellent between the second measurement of the Glittre ADL Test and the third measurement repeated 3–6 days apart (ICC = 0.941, p < 0.001) (Table 2).
Criterion validity
Concurrent validity
There was a strong negative correlation between the time the patients took to complete the Glittre ADL Test and the total distance covered in the 6MWT (rho = − 0.710, p < 0.001). Strong correlations were found between the Glittre ADL Test and NEADL (rho = − 0.841, p < 0.001).
Predictive validity
In the ROC analysis performed according to the completion times of the Glittre ADL Test in pwMS, the AUC value was 0.961 and statistically significant (p < 0.001). With this result, it was determined that the Glittre ADL Test had a high discrimination level for mild and moderate pwMS according to the level of neurological impairment. As a result of this analysis, the recommended cutoff value was chosen as 2.79 min, with 92% sensitivity and 90% specificity, according to the Youden Index [33] (Fig. 1).
Construct validity
Strong correlations were found between the Glittre ADL Test and the EDSS (rho = 0.836, p < 0.001), Mini BESTest (rho = 0.792, p < 0.001), and 5 STST (rho = 0.720, p < 0.001) and a moderate correlation between it and the physical health sub-item of the MSQoL-54 (rho = − 0.591, p = 0.002). No correlation was found between the Glittre ADL Test and the FSS (rho = 0.348, p = 0.096). Of the 5 hypotheses we established, 4 were confirmed (80%). Construct validity of the test was confirmed as more than 75% of the results were consistent with our hypotheses [34] (Table 3).
Known group validity
According to the results for the Glittre ADL Test completion times, a difference was found between the MS and HC groups (p = 0.001). Accordingly, the time to complete the Glittre ADL Test was shorter in healthy participants than in pwMS.
The time to complete the Glittre ADL Test in the MS group was longer than the expected values calculated according to the age and BMI of healthy individuals [27]. In the control group, the results were closer to the expected values. In addition, there was a statistically significant difference between the percentages of the groups reaching the 6MWT expected values [28] (p < 0.05) (Table 4).
Discussion
In our study, the Glittre ADL Test had excellent reliability and strong validity for assessing functional exercise capacity and ADL in pwMS.
In different patient groups in which the validity and reliability of the Glittre ADL Test were investigated, it is recommended that the test should be performed twice for a reliable measurement since the test has a learning effect [16, 19]. Similar to the aforementioned studies, in the present study, it was determined that the test had a learning effect because the completion times of the Glittre ADL Test that was performed for the second time were better than the first application times, and it was more appropriate to perform the Glittre ADL Test twice in pwMS for a more reliable evaluation.
In the literature, it is reported that the Glittre ADL Test performances of patients with scleroderma [35], Parkinson’s disease [20], leprosy [17], COPD [36], and cystic fibrosis [13] are worse than those of healthy individuals. Similar to previous studies, in our study, the pwMS took longer to complete the Glittre ADL Test compared to the healthy controls. In addition, it was determined in the present study that the Glittre ADL Test can distinguish pwMS as mildly and moderately impaired according to the level of neurological impairment. Patients with severe impairment according to the EDSS score were not included in our study. For this reason, the ability of the Glittre ADL Test to distinguish severe impairment from low and moderate impairment can be investigated in future studies. In addition, only RRMS-type pwMS were included in our study. The predictive value of the test in progressive MS forms is unknown. Likewise, Goldman et al. [37] determined that 6MWT can categorize pwMS as mild, moderate, and severe according to the level of neurological impairment. In RRMS-type pwMS with an EDSS score of 4 or below, the test was conducted safely and without any modifications to its administration.
In addition to these results, in our study, the Glittre ADL Test reflected the performance of pwMS in ADL, as in heart failure patients [38] and COPD [12]. Moreover, the Glittre ADL Test could better reflect the performance in ADL than the 6MWT. Since our study was the first in the literature to use the Glittre ADL test in pwMS, this result could not be compared with other studies in pwMS. However, similarly, Driehuis et al. [39] determined that there was a relationship between aerobic capacity and the level of independence in daily living activities inside and outside the home in pwMS with fatigue complaints. In another study, Savcı et al. [40] reported that the limitation in ADL in pwMS is related to functional exercise capacity and that the 6MWT can provide better information than maximum oxygen consumption about the performance of pwMS in their daily activities. Solway et al. [41] also examined functional walking tests and found that among tests such as the 6MWT, 12MWT, 2MWT, and Shuttle walking test, the test that best reflects performance in ADL is the 6MWT. Hena et al. [42] stated that the Glittre ADL Test could provide a more appropriate assessment than the 6MWT in the evaluation of functional capacity and ADL in patients with bronchiectasis. This result reported by Hena et al. [42] was similar to ours. The advantage of the 6MWT is that it requires less material compared to the Glittre ADL Test. However, The Glittre ADL Test can provide more information about daily living activities because it includes many daily life activities such as sitting, standing, going up and down stairs, reaching, and object manipulation, as well as walking.
In our study, there was a relationship between the Glittre ADL Test and 6MWT and balance and the increase in balance disorders of the patients negatively affected their functional exercise capacity. There are many studies in the literature showing the relationship between walking performance and balance in pwMS [43,44,45]. These studies support our results. Moreover, in our study, the correlation between the Mini BESTest and Glittre ADL Test was higher than the correlation with 6MWT. This difference may be explained by the fact that the Glittre ADL Test includes more activities that affect balance such as climbing down stairs, crouching, sitting, and standing up. In this respect, it can be considered that the Glittre ADL Test may reflect additional problems related to balance, apart from gait disorders.
According to research, MS patients’ quality of life is lower than that of healthy individuals [46]. However, it is critical to identify the factors associated with a decrease in quality of life. Studies have reported that there is a relationship between HRQoL and depression, fatigue, psychological distress, and cognitive disorders [46, 47]. Numerous other disease-related factors, such as the severity of the disability or the type of MS, as well as personal factors like education and age, can have an impact on HRQoL [46]. There was a moderate correlation between both the Glittre ADL Test and 6MWT with a physical health sub-item score of MSQoL-54 in our study. In addition to the psychological factors that affect the quality of life, in our study, the relationship between quality of life with aerobic capacity was investigated using only the physical health sub-item of the MSQoL-54. The beneficial impact of exercise approaches on quality of life can be used to support the relationship that we identified [48].
In our study, there was also a correlation between the time to complete the Glittre ADL Test and the time to complete 5 STST in our pwMS. The functional evaluation of both tests, their dependence on speed, the fact that the Glittre ADL Test includes sitting and standing activities of the patient, and different activities that require lower extremity muscle strength can explain this relationship. In addition, there was a correlation between the total distance covered in the 6MWT and the completion time of 5 STST. The fact that walking performance is also related to lower extremity muscle strength can explain the relationship between the two tests. Similar to the findings in our study, other studies have also determined that there is a relationship between lower extremity muscle strength and walking performance, and functional capacity of the lower extremity in pwMS [44, 49].
There are some limitations to our study. One of these is that there was only one evaluator in our study and therefore inter-rater reliability could not be evaluated. In addition, since the Glittre ADL Test includes upper extremity functions, another limitation is that the relationship between test performance and upper extremity functions was not examined. In addition, it should be noted that our study was conducted only in RRMS-type and in pwMS who scored 4 or less according to the EDSS. Our results should not be generalized to all pwMS.
Conclusion
The Glittre ADL Test is a valid and reliable method for the evaluation of the functional exercise capacities and ADL of pwMS. Glittre ADL Test is a submaximal exercise test that does not require expensive materials, is easy to apply, and can be completed in a short time. The advantage of the Glittre ADL Test is that it includes activities that require the use of both the upper and lower extremities. The Glittre ADL Test provides a compherensive evaluation of patients since pwMS can have impairments in both their upper and lower extremities. Another favor of the Glittre ADL Test is that it includes several activities that are similar to daily living activities, in comparison to other functional exercise tests. However, due to the learning effect, it would be more appropriate to perform the Glittre ADL Test twice for an appropriate assessment of pwMS.
Data Availability
The data that support the findings of this study are available from the corresponding author, [G.K.], upon reasonable request.
References
Kamm CP, Uitdehaag BM, Polman CH (2014) Multiple sclerosis: current knowledge and future outlook. Eur Neurol 72:132–141
Compston A, Coles A (2008) Multiple sclerosis. Lancet 372:1502–1517. https://doi.org/10.1016/s0140-6736(08)61620-7
Buzaid A, Dodge MP, Handmacher L, Kiltz PJ (2013) Activities of daily living: evaluation and treatment in persons with multiple sclerosis. Phys Med Rehabil Clin N Am 24:629–638
Langeskov-Christensen M, Heine M, Kwakkel G, Dalgas U (2015) Aerobic capacity in persons with multiple sclerosis: a systematic review and meta-analysis. Sports Med 45:905–923. https://doi.org/10.1007/s40279-015-0307-x
Motl RW, McAuley E, Sandroff BM, Hubbard EA (2015) Descriptive epidemiology of physical activity rates in multiple sclerosis. Acta Neurol Scand 131:422–425. https://doi.org/10.1111/ane.12352
Sandroff B, Dlugonski D, Weikert M et al (2012) Physical activity and multiple sclerosis: new insights regarding inactivity. Acta Neurol Scand 126:256–262
Kuspinar A, Andersen RE, Teng SY et al (2010) Predicting exercise capacity through submaximal fitness tests in persons with multiple sclerosis. Arch Phys Med Rehabil 91:1410–1417
Stickland MK, Butcher SJ, Marciniuk DD, Bhutani M (2012) Assessing exercise limitation using cardiopulmonary exercise testing. Pulm Med 2012:824091. https://doi.org/10.1155/2012/824091
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test (2002) Am J Respir Crit Care Med 166:111–117. https://doi.org/10.1164/ajrccm.166.1.at1102
Lamers I, Maris A, Severijns D et al (2016) Upper limb rehabilitation in people with multiple sclerosis: a systematic review. Neurorehabil Neural Repair 30:773–793
Skumlien S, Hagelund T, Bjørtuft Ø, Ryg MS (2006) A field test of functional status as performance of activities of daily living in COPD patients. Respir Med 100:316–323
Karloh M, Araujo CL, Gulart AA et al (2016) The Glittre-ADL test reflects functional performance measured by physical activities of daily living in patients with chronic obstructive pulmonary disease. Braz J Phys Ther 20(3):223–230
Arikan H, Yatar İ, Calik-Kutukcu E et al (2015) A comparison of respiratory and peripheral muscle strength, functional exercise capacity, activities of daily living and physical fitness in patients with cystic fibrosis and healthy subjects. Res Dev Disabil 45:147–156
Fernandes-Andrade A, Britto R, Soares D et al (2015) The use of the Glittre ADL test to classify the functional capacity of individuals with cardiovascular disease. Physiotherapy 101:e173
Fernandes-Andrade AA, Britto RR, Soares DC, Velloso M et al (2017) Evaluation of the Glittre-ADL test as an instrument for classifying functional capacity of individuals with cardiovascular diseases. Braz J Phys Ther 21:321–328
José A, Dal Corso S (2015) Reproducibility of the six-minute walk test and Glittre ADL-test in patients hospitalized for acute and exacerbated chronic lung disease. Braz J Phys Ther 19:235–242
José A, Soares CLR, Marchiori M et al (2016) The glittre-ADL test can be used to assess the functional performance in patients with leprosy: a controlled transversal study. Edorium J Disabil Rehabil 2:131–137
Lage MC, Coelho GR, Ribeiro-Samora GA et al (2013) Glittre-adl test: a proposal for functional evaluation in heart failure. Jour Resp Cardiov Phy Ter 2:30–31
Monteiro F, Ponce DAN, Silva H et al (2017) Validity and reproducibility of the Glittre ADL-test in obese and post-bariatric surgery patients. Obes Surg 27:110–114
Silva DD, Corrêa J, Normando V et al (2019) Validation and reproducibility of the Glittre activities of daily living test for individuals with Parkinson’s disease. Rev Neurol 16:10
Nicholl C, Lincoln N, Playford E (2002) The reliability and validity of the Nottingham Extended Activities of Daily Living Scale in patients with multiple sclerosis. Mult Scler J 8:372–376
Armutlu K, Korkmaz NC, Keser I et al (2007) The validity and reliability of the Fatigue Severity Scale in Turkish multiple sclerosis patients. Int J Rehabil Res 30:81–85
Franchignoni F, Horak F, Godi M et al (2010) Using psychometric techniques to improve the Balance Evaluation Systems Test: the mini-BESTest. J Rehabil Med 42:323–331
Wallin A, Kierkegaard M, Franzén E, Johansson S (2021) Test-Retest Reliability of the Mini-BESTest in people with mild to moderate multiple sclerosis. Phys Ther 101:1–8. https://doi.org/10.1093/ptj/pzab045
Idiman E, Uzunel F, Ozakbas S et al (2006) Cross-cultural adaptation and validation of multiple sclerosis quality of life questionnaire (MSQOL-54) in a Turkish multiple sclerosis sample. J Neurol Sci 240:77–80
Møller AB, Bibby BM, Skjerbæk AG et al (2012) Validity and variability of the 5-repetition sit-to-stand test in patients with multiple sclerosis. Disabil Rehabil 34:2251–2258. https://doi.org/10.3109/09638288.2012.683479
Reis CMd, Karloh M, Fonseca FR et al (2018) Functional capacity measurement: reference equations for the Glittre Activities of Daily Living test. J Bras Pneumol 44:370–377
Gibbons WJ, Fruchter N, Sloan S, Levy RD (2001) Reference values for a multiple repetition 6-minute walk test in healthy adults older than 20 years. J Cardiopulm Rehabil Prev 21:87–93
Sahin F, Yilmaz F, Ozmaden A et al (2008) Reliability and validity of the Turkish version of the Nottingham Extended Activities of Daily Living Scale. Aging Clin Exp Res 20:400–405
Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121–1123
Altman DG (1990) Practical statistics for medical research. CRC Press
Dancey CP, Reidy J (2007) Statistics without maths for psychology. Pearson education
Kumar R, Indrayan A (2011) Receiver operating characteristic (ROC) curve for medical researchers. Indian Pediatr 48:277–287. https://doi.org/10.1007/s13312-011-0055-4
Terwee CB, Bot SDM, de Boer MR et al (2007) Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 60:34–42. https://doi.org/10.1016/j.jclinepi.2006.03.012
Nonato CP, Azevedo BLPA, Oliveira JGM et al (2020) The Glittre Activities of Daily Living Test in women with scleroderma and its relation to hand function and physical capacity. Clin Biomech 73:71–77. https://doi.org/10.1016/j.clinbiomech.2020.01.008
Corrêa KS, Karloh M, Martins LQ et al (2011) Can the Glittre ADL test differentiate the functional capacity of COPD patients from that of healthy subjects? Braz J Phys Ther 15:467–473
Goldman MD, Marrie RA, Cohen JA (2008) Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls. Mult Scler J 14:383–390
Valadares YD, Corrêa KdS, Silva BO et al (2011) Applicability of activities of daily living tests in individuals with heart failure. Rev Bras de Medicina do Esporte 17:310–314
Driehuis ER, van den Akker LE, de Groot V, Beckerman H (2018) Aerobic capacity explains physical functioning and participation in patients with multiple sclerosis-related fatigue. J Rehabil Med 50:185–192. https://doi.org/10.2340/16501977-2306
Savci S, Inal-Ince D, Arikan H et al (2005) Six-minute walk distance as a measure of functional exercise capacity in multiple sclerosis. Disabil Rehabil 27:1365–1371
Solway S, Brooks D, Lacasse Y, Thomas S (2001) A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest 119:256–270. https://doi.org/10.1378/chest.119.1.256
Hena R, Alaparthi GK, Shyam Krishnan K et al (2018) Cardiorespiratory responses to Glittre ADL test in bronchiectasis: a cross-sectional study. Can Respir J 2018
Sandroff BM, Sosnoff JJ, Motl RW (2013) Physical fitness, walking performance, and gait in multiple sclerosis. J Neurol Sci 328:70–76. https://doi.org/10.1016/j.jns.2013.02.021
Callesen J, Dalgas U, Brincks J, Cattaneo D (2019) How much does balance and muscle strength impact walking in persons with multiple sclerosis? - A cross-sectional study. Mult Scler Relat Disord 29:137–144. https://doi.org/10.1016/j.msard.2019.01.034
Wetzel JL, Fry DK, Pfalzer LA (2011) Six-minute walk test for persons with mild or moderate disability from multiple sclerosis: performance and explanatory factors. Physiother Can 63:166–180
Gil-González I, Martín-Rodríguez A, Conrad R, Pérez-San-Gregorio MÁ (2020) Quality of life in adults with multiple sclerosis: a systematic review. BMJ Open 10:e041249
Yalachkov Y, Soydaş D, Bergmann J et al (2019) Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis. Mult Scler Relat Disord 30:33–37
Halabchi F, Alizadeh Z, Sahraian MA, Abolhasani M (2017) Exercise prescription for patients with multiple sclerosis; potential benefits and practical recommendations. BMC Neurol 17:185. https://doi.org/10.1186/s12883-017-0960-9
Ramari C, Hvid LG, de David AC, Dalgas U (2020) The importance of lower-extremity muscle strength for lower-limb functional capacity in multiple sclerosis: systematic review. Ann Phys Rehabil Med 63:123–137
Author information
Authors and Affiliations
Contributions
Conceptualization: Gözde Kaya, Nezire Köse, Yeliz Salcı; methodology: Gözde Kaya, Nezire Köse, Yeliz Salcı, Aslı Tuncer, Rana Karabudak; formal analysis and investigation: Gözde Kaya, Nezire Köse, Yeliz Salcı, Jale Karakaya; writing—original draft preparation: Gözde Kaya, Nezire Köse, Yeliz Salcı; writing—review and editing: Gözde Kaya, Nezire Köse, Yeliz Salcı; resources: Aslı Tuncer, Rana Karabudak; supervision: Nezire Köse, Yeliz Salcı, Kadriye Armutlu.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kaya, G., Köse, N., Salcı, Y. et al. Reliability and validity of the glittre activities of daily living test in fully ambulatory multiple sclerosis patients. Ir J Med Sci 192, 2379–2386 (2023). https://doi.org/10.1007/s11845-022-03237-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-022-03237-x